Cargando…
Helmet mask and tocilizumab for a patient with hemophagocytic lymphohistiocytosis syndrome and COVID-19: a case report
The management of acute hypoxemic respiratory failure and the effect of antiviral drugs in patients with severe COVID-19 have been debated. This case presents the management of a 64-year-old man COVID-19 patient admitted to the Intensive Care Unit with fever, fatigue, shortness of breath and hemopha...
Autores principales: | Eroglu, Ahmet, Kartal, Seyfi, Saral, Ozlem Bayraktar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833609/ https://www.ncbi.nlm.nih.gov/pubmed/33518836 http://dx.doi.org/10.1016/j.bjane.2020.10.009 |
Ejemplares similares
-
Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report
por: Tholin, Birgitte, et al.
Publicado: (2020) -
Hemophagocytic Lymphohistiocytosis Syndromes
por: Standage, Stephen W., et al.
Publicado: (2014) -
Hemophagocytic Lymphohistiocytosis
por: Kaçar, Ayşe Gonca, et al.
Publicado: (2022) -
Limited efficacy of tocilizumab in adult patients with secondary hemophagocytic lymphohistiocytosis: a retrospective cohort study
por: Kim, Ju Yeon, et al.
Publicado: (2022) -
Hemophagocytic lymphohistiocytosis in the setting of HELLP Syndrome
por: Sarkissian, Sarmen, et al.
Publicado: (2018)